StockData
Accendra Health Inc logo

Accendra Health Inc (ACCH) stock

ACCHWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31Also trades as ACH
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
Share price
Not available yet

Price, market cap and P/E appear here once daily prices are connected.

Accendra Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Accendra Health's revenue for the twelve months ending Sep 30, 2026 was $2.55B, down 7.1% year over year. For fiscal 2025 it was $2.76B, up 3.1% from the year before. Over ten years it grew -11.9% a year on average. The highest annual figure on record is $9.96B in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.76B+3.1%
FY2024Dec 31, 2024$2.68B+5.0%
FY2023Dec 31, 2023$2.55B-74.4%
FY2022Dec 31, 2022$9.96B+1.7%
FY2021Dec 31, 2021$9.79B+15.4%
FY2020Dec 31, 2020$8.48B-7.9%
FY2019Dec 31, 2019$9.21B-2.2%
FY2018Dec 31, 2018$9.42B+1.1%
FY2017Dec 31, 2017$9.32B-4.2%
FY2016Dec 31, 2016$9.72B-0.5%
FY2015Dec 31, 2015$9.77B+3.5%
FY2014Dec 31, 2014$9.44B+4.1%
FY2013Dec 31, 2013$9.07B+2.3%
FY2012Dec 31, 2012$8.87B+2.8%
FY2011Dec 31, 2011$8.63B+6.2%
FY2010Dec 31, 2010$8.12B+1.1%
FY2009Dec 31, 2009$8.04B+11.0%
FY2008Dec 31, 2008$7.24B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$601.78M-13.7%
Q2 FY2026Jun 30, 2026$613.23M-10.1%
Q1 FY2026Mar 31, 2026$627.78M-6.8%
Q4 FY2025Dec 31, 2025$708.97M+2.0%
Q3 FY2025Sep 30, 2025$697.26M+1.5%
Q2 FY2025Jun 30, 2025$681.92M+3.3%
Q1 FY2025Mar 31, 2025$673.88M-74.2%
Q4 FY2024Dec 31, 2024$695.02M-73.8%
Q3 FY2024Sep 30, 2024$686.85M-73.5%
Q2 FY2024Jun 30, 2024$660.40M-74.2%
Q1 FY2024Mar 31, 2024$2.61B+3.6%
Q4 FY2023Dec 31, 2023$2.66B+4.1%
Q3 FY2023Sep 30, 2023$2.59B+3.8%
Q2 FY2023Jun 30, 2023$2.56B+2.5%
Q1 FY2023Mar 31, 2023$2.52B+4.8%
Q4 FY2022Dec 31, 2022$2.55B+3.4%
Q3 FY2022Sep 30, 2022$2.50B-0.2%
Q2 FY2022Jun 30, 2022$2.50B+0.4%
Q1 FY2022Mar 31, 2022$2.41B+3.5%
Q4 FY2021Dec 31, 2021$2.47B+4.5%
Q3 FY2021Sep 30, 2021$2.50B+14.4%
Q2 FY2021Jun 30, 2021$2.49B+37.7%
Q1 FY2021Mar 31, 2021$2.33B+9.6%
Q4 FY2020Dec 31, 2020$2.36B+7.8%
Q3 FY2020Sep 30, 2020$2.19B-4.6%
Q2 FY2020Jun 30, 2020$1.81B-23.9%
Q1 FY2020Mar 31, 2020$2.12B-9.7%
Q4 FY2019Dec 31, 2019$2.19B+3.2%
Q3 FY2019Sep 30, 2019$2.29B-7.0%
Q2 FY2019Jun 30, 2019$2.38B-3.3%
Q1 FY2019Mar 31, 2019$2.35B-0.9%
Q4 FY2018Dec 31, 2018$2.12B-11.2%
Q3 FY2018Sep 30, 2018$2.46B+5.6%
Q2 FY2018Jun 30, 2018$2.46B+8.5%
Q1 FY2018Mar 31, 2018$2.37B+1.9%
Q4 FY2017Dec 31, 2017$2.39B+0.9%
Q3 FY2017Sep 30, 2017$2.33B–
Q2 FY2017Jun 30, 2017$2.27B–
Q1 FY2017Mar 31, 2017$2.33B–
Q4 FY2016Dec 31, 2016$2.37B–

More Accendra Health figures

See a number that looks wrong?